News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

Ascend-nash: A Phase 2B, Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate The Efficacy and Safety of CRV431 In Adult Subjects With Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis

Study Status:

Open for enrollment

Contact Information:

(956) 362-8074

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The main purpose of this study is to investigate the effectiveness and safety of rencofilstat at different dose levels in subjects who have been diagnosed with NASH and advanced fibrosis

Information: 

Principal Investigator
Henry Herrera, MD
Co-PI
Hiram Garcia Jr.
Sponsor
Hepion Pharmaceuticals, Inc.
Type of Trial
Interventional
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram